心肌缺血级联网络和多目标协同干预:从分子机制到治疗创新
Lei Qi1, Jia Yi1, Yuntian Shen1
1Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Medical School of Nantong University, Affiliated Hospital of Nantong University, Nantong University, Nantong, Jiangsu Province 226001, People's Republic of China.
Biochemical pharmacology
|January 16, 2026
概括
心肌缺血涉及复杂的细胞损伤途径. 新疗法针对能量,死亡和炎症网络,以改善心脏的修复和结果.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 心肌缺血损伤是一种复杂的过程,涉及能量代谢,过载,氧化应激,线粒体功能障碍和炎症.
- 重灌可以通过活性氧物种 (ROS),线粒体透性过渡孔 (mPTP) 开放和NLRP3炎症酶激活加剧损伤.
- 细胞内膜网膜 (ER) 的压力有助于细胞亡,产生氧化压力和炎症的循环,导致各种类型的细胞死亡.
研究的目的:
- 审查心肌缺血损伤的多面病理级联.
- 探索针对关键分子通路的当前和新兴治疗策略.
- 突出转向多目标干预和精准医学的转变.
主要方法:
- 对心肌缺血病理生理学和治疗干预措施的现有文献的综述.
- 分析分子机制,包括能量代谢,细胞死亡途径和炎症反应.
- 治疗方法的分类:调节,细胞死亡抑制,代谢/线粒体支持,再生医学和精密医学.
主要成果:
- 缺血-再输液损伤涉及代谢,氧化,炎症和细胞死亡途径的复杂相互作用.
- 治疗策略正在从重血管化演变为多目标干预,包括缺血性调节,细胞死亡抑制剂,代谢调节剂和再生方法.
- 精密医学利用多omics和AI,以及纳米载体药物输送,代表了未来的方向.
结论:
- 针对相互连接的"能量死亡-炎症"网络对于推进心肌缺血症治疗至关重要.
- 未来的疗法应通过综合方法专注于系统性修复和改善临床结果.
- 个性化医疗和先进的药物输送系统有望为更有效的心肌保护提供希望.
相关概念视频
01:28Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
01:29Cardiomyopathy V: Interprofessional Care
339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
01:14Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175
01:17Ischemic Heart Disease: Overview
3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
01:27Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
363
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363